ACTRN12622000584730进行中（未招募）未知
Prehabilitation and Supportive Care in Oncology Treatment of Breast Cancer (PROActive-B): a feasibility study of women with Breast cancer receiving neoadjuvant chemotherapy
Chris O'Brien Lifehouse Hospital0 个研究点目标入组 23 人开始时间: 2022年4月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 23
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- Female
入选标准
- •Study participant Group 1:
- •1. Female, aged over 18 years, diagnosed with breast cancer.
- •2. Has been identified as a patient for the NACT pathway by treating breast surgeon and/or medical oncologist.
- •3. Willingness to provide written consent and able to complete written study assessments and understand instruction for program in English.
- •Study participant Group 2:
- •1. HCP participants who have been involved in the program delivery.
排除标准
- •1. Women lactating, pregnant or of childbearing potential who are not willing to avoid becoming pregnant during the study.
- •2. Unable to give informed consent
- •3. Has completed more than 2 cycles of neoadjuvant chemotherapy at time of enrolment
- •4. Unable to participate due to no computer at home or device to teleconference.
- •5. Contraindications to participation will be determine based on oncologist and exercise physiologist review based on the PAR-Q and the Exercise and Sports Science Australia. The PAR-Q+ will be used as a preliminary tool. The PAR-Q+ is designed to identify symptoms or conditions requiring medical evaluation before participating in exercise. In this setting, cardiac risk is assessed to determine eligibility for NACT and medical records are reviewed before Exercise Physiology assessment. Additional information will be collected based on recommendations of Exercise and Sports Science Australia. These are outlined below:
- •Health history
- •physical activity and exercise history
- •cancer and non-cancer co-morbidities
- •expected treatment related toxicities
- •identification of patient capacity and contraindications
- •psychosocial and physiological constraints, accessibility, preferences, self-efficacy, barriers and facilitators to exercise
- •patient-centred requirements
研究者
相似试验
Unknown
不适用
Pre-operative Prehabilitation in Cancer Surgery - Objective Recovery AssessmentCancerNCT05270577Linkoeping University90
招募中
不适用
Cancer rehabilitation support by cancer counseling centersoncological diseaseDRKS00028121Forschungsstelle für Gesundheitskommunikation und VersorgungsforschungKlinik und Poliklinik für Psychosomatische Medizin und PsychotherapieUniversitätsklinikum Bonn AöR500
已完成
不适用
A cancer rehabilitation and lymphedema care program for patients with resected advanced head and neck cancerCancerISRCTN16929593Ministry of Science and Technology, Taiwan80
已完成
不适用
Oncological occupational rehabilitation to enhance return to work in cancer patients.werkgerelateerde aandoeningenOncological ailment10027656cancerNL-OMON36071Academisch Medisch Centrum130
尚未招募
不适用
Prehabilitation prior to oncological resection for stage I-III pancreatic ductal andenocarcinoma, esophageal and gastric cancer – a prospective feasibility studyC25C16C15Malignant neoplasm of pancreasMalignant neoplasm of stomachMalignant neoplasm of oesophagusDRKS00034212niversitätsklinikum Schleswig-Holstein, Campus Lübeck148